Thailand Cell And Gene Therapy CDMO Market (2025-2031) | Analysis, Share, Competitive Landscape, Forecast, Industry, Size & Revenue, Outlook, Growth, Segmentation, Trends, Companies, Value

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Thailand Country Macro Economic Indicators

3.2 Thailand Cell And Gene Therapy CDMO Market Revenues & Volume, 2021 & 2031F

3.3 Thailand Cell And Gene Therapy CDMO Market - Industry Life Cycle

3.4 Thailand Cell And Gene Therapy CDMO Market - Porter's Five Forces

3.5 Thailand Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Phase, 2021 & 2031F

3.6 Thailand Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.7 Thailand Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Indication, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing investment in research and development in the field of cell and gene therapy in Thailand

4.2.2 Growing demand for personalized medicine and advanced treatment options

4.2.3 Favorable regulatory environment supporting the development and commercialization of cell and gene therapies in Thailand

4.3 Market Restraints

4.3.1 High cost associated with cell and gene therapy development and manufacturing

4.3.2 Limited expertise and infrastructure for cell and gene therapy manufacturing in Thailand

6.1 Thailand Cell And Gene Therapy CDMO Market, By Phase

6.1.1 Overview and Analysis

6.1.2 Thailand Cell And Gene Therapy CDMO Market Revenues & Volume, By Phase, 2021- 2031F

6.1.3 Thailand Cell And Gene Therapy CDMO Market Revenues & Volume, By Pre-clinical, 2021- 2031F

6.1.4 Thailand Cell And Gene Therapy CDMO Market Revenues & Volume, By Clinical, 2021- 2031F

6.2 Thailand Cell And Gene Therapy CDMO Market, By Product Type

6.2.1 Overview and Analysis

6.2.2 Thailand Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene Therapy, 2021- 2031F

6.2.3 Thailand Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene-Modified Cell Therapy, 2021- 2031F

6.2.4 Thailand Cell And Gene Therapy CDMO Market Revenues & Volume, By Cell Therapy, 2021- 2031F

6.3 Thailand Cell And Gene Therapy CDMO Market, By Indication

6.3.1 Overview and Analysis

6.3.2 Thailand Cell And Gene Therapy CDMO Market Revenues & Volume, By Oncology, 2021- 2031F

6.3.3 Thailand Cell And Gene Therapy CDMO Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.3.4 Thailand Cell And Gene Therapy CDMO Market Revenues & Volume, By Neurological disorders, 2021- 2031F

6.3.5 Thailand Cell And Gene Therapy CDMO Market Revenues & Volume, By Rare Diseases, 2021- 2031F

6.3.6 Thailand Cell And Gene Therapy CDMO Market Revenues & Volume, By Others, 2021- 2031F

7.1 Thailand Cell And Gene Therapy CDMO Market Export to Major Countries

7.2 Thailand Cell And Gene Therapy CDMO Market Imports from Major Countries

8.1 Number of partnerships and collaborations between academic institutions, research organizations, and cell and gene therapy CDMOs in Thailand

8.2 Number of clinical trials utilizing cell and gene therapies conducted in Thailand

8.3 Government funding allocated towards the advancement of cell and gene therapy infrastructure and capabilities in Thailand

9.1 Thailand Cell And Gene Therapy CDMO Market Opportunity Assessment, By Phase, 2021 & 2031F

9.2 Thailand Cell And Gene Therapy CDMO Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.3 Thailand Cell And Gene Therapy CDMO Market Opportunity Assessment, By Indication, 2021 & 2031F

10.1 Thailand Cell And Gene Therapy CDMO Market Revenue Share, By Companies, 2024

10.2 Thailand Cell And Gene Therapy CDMO Market Competitive Benchmarking, By Operating and Technical Parameters